Two market reports project substantial growth across related drug-delivery segments. ResearchAndMarkets.com forecasts the global infusion pumps market will rise from USD 14.87 billion in 2026 to USD 25.39 billion by 2035 at a 6.1% compound annual growth rate (CAGR), while MarketsandMarkets projects the injectable drug delivery market will increase from USD 690.23 billion in 2025 to USD 1,034.78 billion by 2030 at an 8.4% CAGR. Infusion pump demand is being supported by chronic disease, population aging, precise medication delivery, digital health integration and expanding home and ambulatory care. Injectable drug delivery growth is being driven by chronic diseases, biologics, advanced formulations and devices including prefilled syringes, autoinjectors, pen injectors, wearable injectors and needle-free systems. North America is the leading region in both reports, while Asia-Pacific is expected to grow fastest for infusion pumps.